***** AZFL ***** Shares Outstanding

New Post Public Reply Private Reply Replies (1) Message Board
Compensated Post
pennybuster
***** AZFL *****



http://www.otcmarkets.com/content/doc/otcm/tier/logo/small/20.png

Shares Outstanding 437,404,545 a/o Sep 31, 2013
Float 180,000,000 a/o Nov 06, 2012
Authorized Shares 500,000,000 a/o Sep 30, 2013


Amazonas Florestal is a diversified forest management company generating profit through innovative, sustainable management of its large tracts of land in the rainforests of Amazonas, Brazil. Amazonas Florestal's sustainable forest management strategy, with its green philosophy and method of cyclical harvesting, preserves ecosystems through habitat and water resource preservation, positioning it as an industry leader in responsible, eco-friendly timber practices.

Headquartered in Miami, FL, Amazonas' goal is to become the leader in sustainable forest management , creating revenue while protecting the biodiversity of the rainforest ecosystem and enhancing the lives of the people who live in it. Through a strategy of selective harvesting, biomass production, and conservation incentives, Amazonas Florestal not only protects one of the world's greatest natural resources, it also makes preservation profitable .

Filings: otcmarkets.com/stock/AZFL/filings




{from the interim financial report , published Oct. 3, 2012; "AMZO" was changed to "AZFL"}


Business Model : The Company's business model is focused on four separate business initiatives: Sustainable Forestry & Timber Operations; Biomass Development; Production & Revenue generation from carbon credits; and Proprietary Programs that enhance their Commitment to Local Communities & their People and Unique Initiatives that protect the integrity and biodiversity of their land's ecosystem.

Mission: To become the leading innovator of sustainable forest management and generate profit while protecting the biodiversity of the rain forest ecosystem and enhancing the lives of the people who live in it.

The company intends to preserve these properties through UN REDD (Reducing Emissions from Deforestation & Forest Degradation) incentive programs , while selectively harvesting their resources through sustainable, "green," government-approved forest management projects. Toward this end, the Company has entered into a strategic relationship with Carbon Forest Group, a financial management Company that is charged with the development and monetization of Carbon Credits through Sustainable Forest Management (SFM), Agro Forestry, and/or R.E.D.D.

Sustainable Forest Management : Amazonas Florestal's sustainable forest management strategy, with its selective method of harvesting timber for the production and commercialization of wood products, targets deforestation, which is one of the primary causes of global warming. Additionally, the Company's strategy rehabilitates ecosystems through habitat and water resource preservation. They make preservation profitable .

REDD Carbon Credit Incentives : The R educed E missions from D eforestation and forest D egradation program is a UN-led initiative aimed at incentivizing the global community to protect its forests. The Company is taking the necessary steps to quantify and certify the carbon "sink" that conserving the vast majority of its land will create.

Clean Energy : A natural by-product from timber production is biomass, which is traditionally discarded as waste wood. the Company plans to recycle this material and convert it into renewable energy. This will create revenues through the direct sale of the energy generated, as well as the Carbon Credit offsets created by this type of activity. In 2012, the Company will conduct a feasibility study for the installation and operation of a thermal energy plant.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Interim Findings from Medicus Pharma's BCC Study

Updated Category News Views 164

Positive Interim Analysis from Medicus Pharma Ltd Medicus Pharma Ltd. (NASDAQ: MDCX) has recently shared exciting interim results from its SKNJCT-003 Phase 2 clinical study, which focuses on a non-invasive approach to treat basal cell carcinoma (BCC) of the skin. This news marks a significant milestone as the company aims to revolutionize the treatment options available...

Continue Reading
DroneShield's Immediate Response Kit Wins Platinum Award for Innovation

Updated Category News Views 161

DroneShield's Immediate Response Kit Gains Recognition for Innovation DroneShield has recently been awarded the prestigious Platinum Award for Innovation by Military and Aerospace Electronics, showcasing its Immediate Response Kit (IRK) as a cornerstone in drone detection and defeat technology. This award is a testament to the exceptional capabilities of the IRK, which...

Continue Reading
Jefferies Holds ABB Rating; Analysts Assess Mixed Results

Updated Category News Views 65

Jefferies Maintains Hold Rating on ABB Stock Jefferies recently continued its Hold rating for ABB Ltd (NYSE: ABB) and set a price target of CHF50.00, following the company's third-quarter performance report. The report showcased a mixed array of results, with certain metrics outperforming expectations while others showed disappointing trends. During the third quarter, ABB...

Continue Reading
Surgical Clips Market Projected to Reach $1.8 Billion Soon

Updated Category News Views 211

Overview of the Surgical Clips Market Recent analysis of the surgical clips market reveals an impressive valuation of USD 655.9 million in 2023, with projections indicating a potential growth to USD 1.8 billion by 2032. This remarkable increase is attributed to a compound annual growth rate (CAGR) of 11.9% from 2024. Understanding Surgical Clips and Their Importance...

Continue Reading
Public Disclosure of Opening Position by Keywords Studios Plc

Updated Category News Views 74

Public Opening Position Disclosure for Keywords Studios Plc This document provides important information about a public opening position disclosure related to Keywords Studios Plc. It includes details about individuals or entities holding 1% or more of relevant securities. This disclosure is made in accordance with Rule 8.3 of the Takeover Code, which ensures that all...

Continue Reading